Search research articles
Contact Us
Filters
Showing results (21-30 of 94) with videos related to
Page
of 10
Sort By:
Pathologie-Biologie
|
January 1, 1985
[HLA and myasthenia. Subdivision in 3 categories]
A Elchidiac, V Lepage, S Berrih, et al.
Tissue Antigens
|
November 1, 1977
A study of 15 anti-HLA-Bw16 sera
V Lepage, C Dehay, J Guillet, et al.
Tissue Antigens
|
July 1, 1989
Definition of a new supertypic HLA class II determinant (LAR) associated with HLA-DR2 and -DR7
M Colombani, N Sansonetti, V Lepage, et al.
Lancet (London, England)
|
February 14, 2003
HLA in French patients with variant Creutzfeldt-Jakob disease
J L Laplanche, V Lepage, K Peoc'h, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
|
February 1, 1994
Determination of DRB alleles using PCR amplification and allele-specific primers
V Lepage, V Schaeffer, C Mallet, et al.
European Journal of Immunology
|
December 1, 1978
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells
L Boumsell, A Bernard, V Lepage, et al.
Advances in Nephrology From the Necker Hospital
|
January 1, 1992
Molecular approaches to the relationships between HLA and susceptibility to diseases
L Degos, I Khalil, O Blanchet, et al.
Immunogenetics
|
January 1, 1989
Xenogeneic monoclonal HLA-specific antibodies defining mouse lymphocyte determinants encoded by the H-2 complex
A Rocca, D Besluau, V Lepage, et al.
Revue Francaise De Transfusion Et Immuno-Hematologie
|
April 1, 1986
[Study of the HLA-DQ system by the complement fixation test on lymphocytes stimulated by phytohemagglutinin. Existence of HLA-DQX allele(s)]
A Chidiac, M Colombani, V Lepage, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
October 14, 2024
A 14-year retrospective of HER2 + metastatic breast cancer treatment at one comprehensive cancer center: Impact of the trastuzumab/pertuzumab and trastuzumab-emtansine sequence versus trastuzumab on overall survival
V Lepage, J Clarenne, B Fulbert, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 94) with videos related to
Sort By:
Page
of 10
Pathologie-Biologie
|
January 1, 1985
[HLA and myasthenia. Subdivision in 3 categories]
A Elchidiac, V Lepage, S Berrih, et al.
Tissue Antigens
|
November 1, 1977
A study of 15 anti-HLA-Bw16 sera
V Lepage, C Dehay, J Guillet, et al.
Tissue Antigens
|
July 1, 1989
Definition of a new supertypic HLA class II determinant (LAR) associated with HLA-DR2 and -DR7
M Colombani, N Sansonetti, V Lepage, et al.
Lancet (London, England)
|
February 14, 2003
HLA in French patients with variant Creutzfeldt-Jakob disease
J L Laplanche, V Lepage, K Peoc'h, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
|
February 1, 1994
Determination of DRB alleles using PCR amplification and allele-specific primers
V Lepage, V Schaeffer, C Mallet, et al.
European Journal of Immunology
|
December 1, 1978
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells
L Boumsell, A Bernard, V Lepage, et al.
Advances in Nephrology From the Necker Hospital
|
January 1, 1992
Molecular approaches to the relationships between HLA and susceptibility to diseases
L Degos, I Khalil, O Blanchet, et al.
Immunogenetics
|
January 1, 1989
Xenogeneic monoclonal HLA-specific antibodies defining mouse lymphocyte determinants encoded by the H-2 complex
A Rocca, D Besluau, V Lepage, et al.
Revue Francaise De Transfusion Et Immuno-Hematologie
|
April 1, 1986
[Study of the HLA-DQ system by the complement fixation test on lymphocytes stimulated by phytohemagglutinin. Existence of HLA-DQX allele(s)]
A Chidiac, M Colombani, V Lepage, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
October 14, 2024
A 14-year retrospective of HER2 + metastatic breast cancer treatment at one comprehensive cancer center: Impact of the trastuzumab/pertuzumab and trastuzumab-emtansine sequence versus trastuzumab on overall survival
V Lepage, J Clarenne, B Fulbert, et al.
Page
of 10